The expression profiles of cancer-related checkpoints showed that the majority of checkpoint-target genes had low expression levels in the high-risk group, and only TNFRSF25, TNFRSF4, TNFRSF14, TNFRSF18, and CD276 were upregulated in the high-risk group. Here, CD276 is linked to cancer.